Biotech Surge – COVID-19 Cure is Just the Start

By Michael Cohick, Senior ETF Product Manager, VanEck Recent positive developments in COVID-19 vaccines have spurred a wave of market exuberance, lifting share prices of biotech companies at the forefront of the vaccine race. The broader NASDAQ Biotechnology Index has also benefited from the rally,...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.